KR20050053071A - Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation - Google Patents
Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation Download PDFInfo
- Publication number
- KR20050053071A KR20050053071A KR1020030086671A KR20030086671A KR20050053071A KR 20050053071 A KR20050053071 A KR 20050053071A KR 1020030086671 A KR1020030086671 A KR 1020030086671A KR 20030086671 A KR20030086671 A KR 20030086671A KR 20050053071 A KR20050053071 A KR 20050053071A
- Authority
- KR
- South Korea
- Prior art keywords
- kelp
- oligosaccharide
- polysaccharide
- functional food
- extract
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 42
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 39
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 37
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 37
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 37
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 235000013376 functional food Nutrition 0.000 title claims abstract description 20
- 206010010774 Constipation Diseases 0.000 title claims abstract description 16
- 230000002265 prevention Effects 0.000 title claims abstract description 10
- 230000006872 improvement Effects 0.000 title claims description 8
- 150000004676 glycans Chemical class 0.000 title abstract 3
- 241001466453 Laminaria Species 0.000 title description 2
- 241000512259 Ascophyllum nodosum Species 0.000 claims abstract description 50
- 230000000694 effects Effects 0.000 claims abstract description 13
- 239000002253 acid Substances 0.000 claims abstract description 10
- 230000036541 health Effects 0.000 claims abstract description 10
- 238000010438 heat treatment Methods 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims abstract description 5
- 150000004804 polysaccharides Chemical class 0.000 claims description 34
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 21
- 235000013361 beverage Nutrition 0.000 claims description 15
- 239000000783 alginic acid Substances 0.000 claims description 6
- 235000010443 alginic acid Nutrition 0.000 claims description 6
- 229920000615 alginic acid Polymers 0.000 claims description 6
- 229960001126 alginic acid Drugs 0.000 claims description 6
- 235000015872 dietary supplement Nutrition 0.000 claims description 6
- -1 alginic acid oligosaccharides Chemical class 0.000 claims description 4
- 244000167230 Lonicera japonica Species 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 15
- 210000000813 small intestine Anatomy 0.000 abstract description 11
- 210000000936 intestine Anatomy 0.000 abstract description 5
- 238000009499 grossing Methods 0.000 abstract 1
- 241001474374 Blennius Species 0.000 description 17
- 238000000605 extraction Methods 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- 235000021590 normal diet Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013402 health food Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 235000013325 dietary fiber Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000003405 ileum Anatomy 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000005717 Laminarin Substances 0.000 description 2
- 229920001543 Laminarin Polymers 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241001017597 Saccharina ochotensis Species 0.000 description 2
- 241000015194 Saccharina religiosa Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229960003975 potassium Drugs 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 150000003735 xanthophylls Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/3262—Foods, ingredients or supplements having a functional effect on health having an effect on blood cholesterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/032—Citric acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/28—Oligosaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
본 발명은 산 및 고온가열 처리하여 얻어진 다시마 다당 및 올리고당 추출물을 유효성분으로 함유하는 기능성 식품 조성물에 관한 것으로, 본 발명의 다시마 다당 및 올리고당은 소장내의 음식물의 이동 속도를 촉진시키고, 장관의 운동을 촉진하여 배변을 원활하게 하는 효과를 나타내므로, 변비 개선 및 예방용 기능성 식품 조성물로써 기능성 음료 등의 건강기능식품에 사용할 수 있다.The present invention relates to a functional food composition containing an extract of kelp polysaccharide and oligosaccharide obtained by acid and high temperature heating as an active ingredient. The kelp polysaccharide and oligosaccharide of the present invention promotes the movement of food in the small intestine and promotes the movement of the intestine. Since it exhibits the effect of smoothing bowel movements, it can be used in health functional foods such as functional drinks as a functional food composition for improving constipation and prevention.
Description
본 발명은 산 및 고온가열 처리하여 얻어진 다시마 다당 및 올리고당 추출물을 유효성분으로 함유하는 변비 개선 및 예방용 기능성 식품 조성물에 관한 것이다.The present invention relates to a functional food composition for improving and preventing constipation, containing the extract of kelp polysaccharide and oligosaccharide obtained by acid and high temperature heating as an active ingredient.
최근 식생활 수준의 향상으로 동물성 지방질 과다 섭취, 운동부족, 과음 등으로 인해 성인병의 주요한 원인이 되고 있는 비만이 급격하게 증가하고 있는 상황이다(보건복지부, 1997년도 국민 영양 조사 결과서, p37, 1997). 따라서, 식이섬유의 섭취 부족으로 인한 변비의 발생이 크게 확대되어 있으며, 이것이 성인병의 병인이 되는 것도 큰 문제로 지적되고 있다. In recent years, obesity, which is a major cause of adult diseases due to excessive intake of animal fat, lack of exercise, and excessive drinking, has been increasing rapidly (Ministry of Health and Welfare, 1997 National Nutrition Survey Report, p37, 1997). Therefore, the incidence of constipation due to lack of intake of dietary fiber has been greatly enlarged, and it is also pointed out that this is a cause of adult disease.
식이섬유는 식물성 식품에 널리 분포하고 있는데, 식습관이 당질 식품 위주에서 단백질과 지질 식품 위주로 변화하여 섭취량이 크게 줄어들고 있다. 이러한 식이섬유의 부족은 어쩔 수 없이 다른 식품이나 가공품으로 대체되어야 하므로, 최근에 주목을 끌고 있는 것이 해조 다당이다. Dietary fiber is widely distributed in plant foods, and eating habits are changing from sugar-based foods to protein and lipid-based foods. This lack of dietary fiber is inevitably replaced by other foods or processed products, the seaweed polysaccharide has recently attracted attention.
해조 다당은 다양한 종류가 있으나 최근에 알긴산을 중심으로 그 기능이 인정을 받고 있으며, 가공 식품 소재로 널리 이용되고 있다. Seaweed polysaccharides come in a variety of varieties, but their functions have recently been recognized around alginic acid and are widely used as processed food materials.
해조류는 지질 저하, 콜레스테롤 저하, 변비 개선, 중금속 배출 등의 기능을 가지고 있는 건강 식품 소재로서 각광받으며, 이의 적절한 이용 방안에 대한 관심이 높아지고 있고, 아울러 다양한 건강 기능성 제품으로의 개발이 활발하게 진행되고 있다. 최근에는 산업적 생산이 가능한 해조 올리고당 제조 기술의 개발로 해조의 기능성 식품 소재로의 이용에 대한 기술적 접근이 많이 이루어져 있기는 하지만 여전히 제품화에는 많은 연구가 진행되어야 할 것으로 여겨진다(Beaumont JL. et al., Bull WHO, 43, pp891-897, 1970). 근래 들어 해조 다당이 미량 첨가된 기능성 해조 음료가 소개되기도 하였으나, 해조를 소재로 한 것은 아니며, 일본의 경우에도 해조를 이용한 다양한 제품이 개발되고는 있으나 단순 가공의 수준에 머물러있는 실정이다. 따라서, 이러한 여러 가지 현황을 검토해 볼 때 아직 해조를 이용한 기능성 소재 및 제품 개발의 가능성이 충분히 있는 것으로 판단된다.Seaweeds are spotlighted as a health food material with functions of lowering lipids, lowering cholesterol, improving constipation, and releasing heavy metals, and there is increasing interest in their proper use, and development of various health functional products is actively progressing. have. In recent years, the development of seaweed oligosaccharide manufacturing technology capable of industrial production has made a lot of technical approaches to the use of seaweed as a functional food material, but it is still considered to be a lot of research to commercialize (Beaumont JL. Et al., Bull WHO , 43 , pp891-897, 1970). Recently, functional seaweed beverages containing trace amounts of seaweed polysaccharides have been introduced, but they are not based on seaweed, and in the case of Japan, various products using seaweed have been developed, but remain at the level of simple processing. Therefore, when reviewing these various conditions, it seems that there is still plenty of possibility of developing functional materials and products using seaweed.
다시마(Laminaria)는 갈조식물 다시마목 다시마과의 한 속으로, 전통적인 해조식품이다. 한국·일본·캄차카반도·사할린섬 등의 태평양 연안에 분포하며, 크기는 1.5 내지 3.5 m이고, 나비는 25 내지 40 cm이다. 다시마속 식물은 태평양 연안에 20여 종이 자라고 있으며, 10 m 이상의 큰 종류도 있는데, 주요 종으로는 참다시마(L. japonica), 오호츠크다시마(L. ochotensis), 애기다시마(L. religiosa) 등이 있다. 다시마에는 카로틴류, 크산토필류, 엽록소 등의 여러 가지 색소 외에 탄소동화작용으로 만들어지는 마니트, 라미나린 등의 탄수화물과 세포벽의 성분인 알긴산이 많이 들어 있고, 요오드, 비타민 B2, 글루탐산 등의 아미노산이 들어 있다.Kelp (Laminaria) is a genus of seaweed kelp and kelp, a traditional seaweed food. It is distributed in the Pacific coasts of Korea, Japan, Kamchatka Peninsula, Sakhalin Island, etc., and the size is 1.5 to 3.5 m, and the butterfly is 25 to 40 cm. Kelp plants grow over 20 species on the Pacific coast, and there are also large varieties of more than 10 m. The main species are L. japonica, L. ochotensis, and L. religiosa. have. In addition to various pigments such as carotene, xanthophylls, and chlorophyll, kelp contains a lot of carbohydrates, such as manit and laminarin, which are made by carbon assimilation, and alginic acid, which is a component of cell walls. This contains.
다시마의 성분은 종류에 따라서 다르지만, 대체로 수분 16 %, 단백질 7 %, 지방 1.5 %, 탄수화물 49 %, 무기염류 26.5 % 정도이며, 탄수화물의 20 %는 섬유소이고 나머지는 알긴산과 라미나린 등 다당류이다. 특히 요오드·칼륨·칼슘 등 무기염류가 많이 들어 있다.Although the constituents of kelp vary depending on the type, they are generally 16% moisture, 7% protein, 1.5% fat, 49% carbohydrates, and 26.5% inorganic salts. 20% of carbohydrates are fibrin and the rest are polysaccharides such as alginic acid and laminarin. In particular, many inorganic salts, such as iodine, potassium, and calcium, are contained.
한편, 한국특허출원 제1991-011992호(공개93-1825)에서는 미역, 다시마를 이용한 음료의 제조방법에 관하여 개시하고 있고, 한국특허출원 제1995-015089호에서는 미역귀를 주성분으로 한 쥬스 제조방법 등에 관하여 개시하고 있으나, 다시마 그 자체를 이용하여 음료나 쥬스를 제조하는 방법으로 식감이 좋지 못하고, 특유의 비린 맛과 향기 등이 강하여 음료로서 부적합한 면이 있다.Meanwhile, Korean Patent Application No. 1991-011992 (Publication 93-1825) discloses a method for preparing a beverage using seaweed and kelp, and Korean Patent Application No. 1995-015089 discloses a method for preparing juice containing seaweed ear as a main ingredient. It is disclosed in relation to the present invention, but the texture is not good by the method of preparing a drink or juice using the kelp itself, and the unique fishy taste and aroma are strong, so that it is unsuitable as a drink.
따라서, 본 발명자들은 다시마의 여러 생리활성 효능을 검색하던 중 다시마 다당 및 올리고당 추출물의 장기의 운동에 미치는 영향을 실험하여 그 효과를 확인함으로써 본 발명을 완성하였다.Accordingly, the present inventors completed the present invention by examining the effects of the tangle polysaccharide and oligosaccharide extract on the exercise of organs while searching for various bioactive effects of kelp.
본 발명의 목적은 산 및 고온가열 처리하여 얻어진 다시마 다당 및 올리고당 추출물을 유효성분으로 함유하는 변비 개선 및 예방용 기능성 식품 조성물을 제공하는 것이다. It is an object of the present invention to provide a functional food composition for improving constipation and preventing constipation containing an extract of kelp polysaccharide and oligosaccharide obtained by acid and high temperature heating as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 산 및 고온가열 처리하여 얻어진 다시마 올리고당 추출물을 유효성분으로 함유하는 변비 개선 및 예방용 기능성 식품 조성물을 제공한다.In order to achieve the above object, the present invention provides a functional food composition for constipation improvement and prevention containing the kelp oligosaccharide extract obtained by acid and high temperature heating treatment as an active ingredient.
상기 다시마는 참다시마(L. japonica), 오호츠크다시마(L. ochotensis), 애기다시마(L. religiosa) 등이며, 바람직하게는 참다시마이다.The kelp is L. japonica , L. ochotensis , L. religiosa , and the like.
상기 산 처리는 구연산, 초산, 사과산 등의 약산, 바람직하게는 구연산으로 처리하는 것을 의미한다. The acid treatment means treatment with weak acids, preferably citric acid, such as citric acid, acetic acid and malic acid.
상기 고온처리는 100 내지 150 ℃, 바람직하게는 120 ℃에서 10 분 내지 5시간, 바람직하게는 60 분간 가열 처리하는 것을 포함한다.The high temperature treatment includes heat treatment at 100 to 150 ° C., preferably at 120 ° C. for 10 minutes to 5 hours, preferably 60 minutes.
상기 다시마 다당 및 올리고당은 주로 알긴산 올리고당임을 특징으로 한다.The kelp polysaccharides and oligosaccharides are characterized in that they are mainly alginic acid oligosaccharides.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명의 다시마 다당 및 올리고당 추출물은 다시마를 동결건조 후 마쇄하여 분말화 한 후, 다시마 건조 중량의 약 3 내지 60배, 바람직하게는 약 20 내지 40배에 달하는 부피의 구연산, 초산, 사과산 등과 같은 약산, 바람직하게는 0.5 % 구연산 용액으로 120 내지 150 ℃, 바람직하게는 120 ℃의 추출 온도에서 약 10분 내지 5 시간, 바람직하게는 60분 동안 열수 추출, 냉침 추출, 환류 냉각 추출 또는 초음파 추출 등의 추출방법, 바람직하게는 열수 추출로 1회 내지 5회, 바람직하게는 2 내지 3회 연속 추출하여 수득한 후, 감압여과하고 여액을 진공회전농축기로 20 내지 100 ℃, 바람직하게는 50 내지 70 ℃에서 감압농축하여 본 발명의 다시마 다당 및 올리고당 추출물을 수득할 수 있다.The kelp polysaccharide and oligosaccharide extract of the present invention is lyophilized after lyophilization and pulverized, and then the volume of citric acid, acetic acid, malic acid, etc., which is about 3 to 60 times the dry weight of kelp, preferably about 20 to 40 times Hydrothermal extraction, cold extraction, reflux cooling extraction or ultrasonic extraction, for about 10 minutes to 5 hours, preferably 60 minutes, at an extraction temperature of 120 to 150 ° C., preferably 120 ° C., with a weak acid, preferably 0.5% citric acid solution. Extraction method, preferably obtained by continuous extraction once to 5 times, preferably 2 to 3 times by hot water extraction, and then filtered under reduced pressure and the filtrate is 20 to 100 ℃, preferably 50 to 70 with a vacuum rotary concentrator Concentration under reduced pressure at ℃ can be obtained the polysaccharide and oligosaccharide extract of the present invention.
본 발명은 상기 방법으로 산 및 고온가열 처리하여 수득된 다시마 다당 및 올리고당 추출물을 함유하는 변비 개선 및 예방용 기능성 식품 조성물을 제공한다.The present invention provides a functional food composition for constipation improvement and prevention containing the extracts of kelp polysaccharide and oligosaccharide obtained by acid and high temperature heating treatment in the above method.
상기 제법으로부터 수득된 다시마 다당 및 올리고당 추출물은 소장내의 음식물의 이동 속도를 촉진시키고, 장관의 운동을 촉진하여 배변을 원활하게 하는 효과를 각종 실험을 통하여 확인하였다.Kelp polysaccharide and oligosaccharide extract obtained from the above method was confirmed through various experiments to promote the movement speed of the food in the small intestine, promote the movement of the intestine to facilitate bowel movement.
본 발명의 변비 개선 및 예방용 기능성 식품 조성물은 조성물 총 중량에 대하여 상기 추출물을 0.02 ~ 90 중량 %로 포함한다.Functional food composition for constipation improvement and prevention of the present invention comprises the extract in an amount of 0.02 to 90% by weight based on the total weight of the composition.
또한, 본 발명은 변비 예방 및 개선 효과를 나타내는 상기 다시마 추출물, 및 식품학적으로 허용되는 식품 보조 첨가제를 함유하는 건강기능식품을 제공한다.In addition, the present invention provides a dietary supplement containing the kelp extract, and a food supplement acceptable food supplement additive exhibiting a constipation prevention and improvement effect.
본 발명의 다시마 다당 및 올리고당 추출물 자체는 독성 및 부작용이 거의 없으므로 예방 목적으로 장기간 복용 시에도 안심하고 사용할 수 있다. The kelp polysaccharide and oligosaccharide extract of the present invention has almost no toxicity and side effects, and therefore can be used with confidence even for prolonged administration.
따라서, 본 발명의 상기 추출물은 변비 개선 및 예방 효과를 목적으로 식품 또는 음료에 첨가될 수 있다. 본 추출물을 첨가할 수 있는 식품으로는, 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강기능 식품류 등이 있다. 이 때, 식품 또는 음료 중의 상기 추출물의 양, 즉 일반적으로 본 발명의 건강기능 조성물은 전체 식품 중량의 0.01 내지 15 % 중량으로 가할 수 있으며, 건강 음료 조성물은 100 ㎖를 기준으로 0.02 내지 10 g, 바람직하게는 0.3 내지 1 g의 비율로 가할 수 있다. Therefore, the extract of the present invention can be added to food or beverages for the purpose of improving constipation and preventing. Examples of the food to which the extract can be added include various foods, beverages, gums, teas, vitamin complexes, and health functional foods. At this time, the amount of the extract in the food or beverage, that is, in general, the health functional composition of the present invention can be added to 0.01 to 15% by weight of the total food weight, the health beverage composition is 0.02 to 10 g, based on 100 ml, Preferably it can be added in the ratio of 0.3-1 g.
본 발명의 건강 음료 조성물은 지시된 비율로, 필수 성분으로서 상기 추출물을 함유하는 외에는 액체성분에는 특별한 제한점은 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물의 예는 모노사카라이드, 예를 들어, 포도당, 과당 등; 디사카라이드, 예를 들어 말토스, 슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물, 예를 들어 레바우디오시드 A, 글리시르히진등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 1 내지 20 g, 바람직하게는 약 5 내지 12 g이다.The health beverage composition of the present invention has no particular limitation on the liquid component except for containing the extract as an essential ingredient in the ratios indicated, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks. Examples of the above-mentioned natural carbohydrates include monosaccharides such as glucose, fructose and the like; Disaccharides such as maltose, sucrose and the like; And conventional sugars such as polysaccharides such as dextrin, cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol. As flavoring agents other than those mentioned above, natural flavoring agents (tauumatin, stevia extract, for example rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used. . The proportion of such natural carbohydrates is generally about 1 to 20 g, preferably about 5 to 12 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 조성물들은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하진 않지만 본 발명의 조성물 100 중량부 당 0 내지 약 20 중량부의 범위에서 선택되는 것이 일반적이다. In addition to the above, the composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese and chocolate), pectic acid and salts thereof, alginic acid and its Salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like. The compositions of the present invention may also contain pulp for the production of natural fruit juices and fruit juice beverages and vegetable beverages. These components can be used independently or in combination. The proportion of such additives is not so critical but is generally selected from the range of 0 to about 20 parts by weight per 100 parts by weight of the composition of the present invention.
본 발명은 다음의 실시예에 의거하여 더욱 상세히 설명되나, 본 발명이 이에 의해 제한되지는 않는다.The present invention is described in more detail based on the following examples, although the present invention is not limited thereto.
실시예 1. 다시마 올리고당 추출물의 제조Example 1 Preparation of Kelp Oligosaccharide Extract
동해 인근 시장에서 구입한 다시마를 시료로 하여 깨끗이 수세하고 건조한 후, 다시마 100 g에 0.5 % 구연산 용액 3 ℓ를 가하고 120 ℃에서 60분 이상 가열 처리하여 추출하는 과정을 2회 반복 수행함으로써, 다시마 다당 및 올리고당 추출물 5 ℓ를 수득하였다.Water washed and dried with seaweed purchased from a market near the East Sea, dried, and 100 ml of kelp was added to 3 l of 0.5% citric acid solution and heated and extracted at 120 ° C for 60 minutes. And 5 liters of oligosaccharide extract.
실시예 2. 다시마 음료의 제조Example 2. Preparation of Kelp Beverage
상기 실시예 1에서 수득한 다시마 다당 및 올리고당 추출물에 하기 표 1에 기재된 성분의 음료 첨가물을 일정비율 첨가하여 다시마 음료를 제조하였다. A kelp drink was prepared by adding a predetermined ratio of the beverage additives of the ingredients shown in Table 1 to the kelp polysaccharide and oligosaccharide extracts obtained in Example 1.
실험예 1. 다시마 다당 및 올리고당 추출물의 소장 및 회장 운동에 미치는 효과Experimental Example 1. Effect of Kelp Polysaccharide and Oligosaccharide Extract on Small and Small Intestine Exercise
1-1. 실험동물의 소장 운동에 미치는 효과1-1. Effect on Small Intestine Movement in Laboratory Animals
상기 실시예 1에서 수득한 다시마 다당 및 올리고당 추출물이 소장 운동에 미치는 효과를 알아보기 위하여, 실험동물로 20 시간 절식시킨 체중 20-25 g의 수컷 쥐(mouse, 대한실험동물센터로부터 분양 받음) 10마리를 한 군으로 하여 세군으로 나눈 다음, 정상식이를 섭취시킨 정상식이군과 함께 시료로 실시예 1의 다시마 다당 및 올리고당 추출물, 실시예 2의 다시마 음료를 각군에 10 ㎖/kg으로 경구투여하고 1시간 후에 차골 밀(charcoal meal)(탄밀 50 %, 아라비아(arabia) 고무 현탁액)을 0.2 ㎖/마우스로 하여 경구 투여한 다음 30분 후 치사시켜 개복하고 유문부에서 맹장직전까지 적출한 후 차골 밀의 이동거리(cm)를 측정하여 하기 수학식 1에 의해 소장 운동 정도를 비교하여 그 효과를 평가하였다. In order to examine the effects of the seaweed polysaccharide and oligosaccharide extracts obtained in Example 1 on small intestine movement, 20-25 g of male rats (mouse, received from Korea Experimental Animal Center) that were fasted for 20 hours as experimental animals 10 One group was divided into three groups, and then oral administration of the kelp polysaccharide and oligosaccharide extract of Example 1 and the kelp drink of Example 2 to each group with a normal diet group ingested a normal diet to each group 1 After time, oral administration of charcoal meal (charcoal meal 50%, arabia rubber suspension) at 0.2 ml / mouse, and after 30 minutes of death, laparotomy and extraction from the pyloric region just before the cecum, (cm) was measured, and the effect of the small intestine exercise was compared by the following equation (1).
그 결과, 하기 표 2에 나타낸 것처럼 정상식이군에서는 차골 밀의 이동 거리가 63.4 %이던 것이 상기 실시예 1의 다시마 다당 및 올리고당 추출물의 투여로 73.6 %의 이동거리를 나타내어 비율로 보면 20 % 정도 더 이동한 것으로 확인되었으며, 상기 실시예 2의 다시마 음료의 경우 이동거리가 78.2 %로 정상 식이군에 비해 24 % 정도 더 이동한 것으로 나타났다. As a result, as shown in Table 2, in the normal diet group, the movement distance of chagol mill was 63.4%, which was 73.6% by the administration of the kelp polysaccharide and oligosaccharide extract of Example 1, which was further moved by about 20%. In the case of the kelp drink of Example 2, the moving distance was 78.2%, which was 24% more than that of the normal diet group.
이와 같은 결과로 다시마 다당 및 올리고당 추출물이 소장내의 음식물의 이동을 촉진시켜 배변 효과를 높일 수 있음을 알 수 있었다. As a result, it was found that polysaccharide and oligosaccharide extracts can increase the bowel effect by promoting the movement of food in the small intestine.
1-2. 실험동물의 회장 운동에 미치는 효과1-2. Effect on ileal movement of experimental animals
상기 실시예 1에서 수득한 다시마 다당 및 올리고당 추출물이 회장 운동에 미치는 효과를 알아보기 위하여, 실험동물로 토끼에 상기 실시예 1의 다시마 다당 및 올리고당 추출물 및 상기 실시예 2의 다시마 음료를 10 ㎖/kg으로 급식시켜 소장을 노출하고 맹장과 소장의 접합부에서 10-15 cm되는 곳으로부터 30 cm 가량의 회장을 절단해 내어 티로이드 용액(Tyroid solution)에 담그고 주사기(syringe)를 이용하여 장부의 내용물을 씻어 내어 회장 표본을 적출하고, 적출 회장은 2.0-2.5 cm 길이로 절단하여 37 ℃, 95 % 산소(O2) - 5 % 이산화탄소(CO2) 혼합가스로 포화시킨 티로이드 용액이 담긴 오르간 베스(organ bath) 내에 현수하고 적출 표본을 안정화시킨 후 시험 시료를 가하여 아이소토닉(isotonic) 수축 정도의 변화를 대조(공)시험에 대한 %로 나타내었다.In order to determine the effect of the kelp polysaccharide and oligosaccharide extract obtained in Example 1 on the ileal motility, 10 ml / of the kelp polysaccharide and oligosaccharide extract of Example 1 and the kelp drink of Example 2 to the rabbit as an experimental animal kg to expose the small intestine, cut about 30 cm of ileum from 10-15 cm at the junction of the cecum and small intestine, dip it into a Tyroid solution, and use the syringe to The ileum specimens were washed out, and the ileum was cut into 2.0-2.5 cm lengths and organ bath containing a thyroid solution saturated with 37 ° C. and 95% oxygen (O 2 ) to 5% carbon dioxide (CO 2 ) mixed gas. Suspension in the organ bath), and after stabilizing the extracted sample, the test sample was added to express the change in the degree of isotonic shrinkage in% of the control (co) test.
그 결과, 하기 표 3에 나타낸 것처럼 상기 실시예 1의 다시마 다당 및 올리고당 추출물 및 상기 실시예 2의 다시마 음료 투여시 용량 의존적으로 토끼의 장관의 수축력이 증가되었다. 이는 상기 다시마 다당 및 올리고당 추출물이 토끼의 장관을 자극하여 장관의 운동을 촉진시키는 효과가 있다는 증거로 사료된다.As a result, as shown in Table 3 below, the contractile force of the intestinal tract of the rabbit was increased in dose-dependent administration of the kelp polysaccharide and oligosaccharide extract of Example 1 and the kelp drink of Example 2. This is considered evidence that the kelp polysaccharide and oligosaccharide extract has an effect of stimulating the exercise of the intestine by stimulating the intestine of the rabbit.
이와 같은 결과로 다시마 다당 및 올리고당 추출물은 소장내의 음식물의 이동 속도를 촉진시키고, 장관의 운동을 촉진하여 배변을 원활하게 함으로서 변비의 예방 및 개선 및 나아가 체내의 다양한 성인병의 예방에 기여를 할 수 있을 것으로 생각된다. As a result, kelp polysaccharide and oligosaccharide extract may promote the movement of food in the small intestine and promote bowel movements to facilitate bowel movements, which may contribute to the prevention and improvement of constipation and further prevention of various adult diseases in the body. It is thought to be.
하기에 상기 조성물의 제제예를 설명하나, 이는 본 발명을 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Examples of the formulation of the composition are described below, but are not intended to limit the present invention but to explain in detail only.
제제예 1. 건강 식품의 제조Formulation Example 1 Preparation of Healthy Food
실시예 1의 다시마 다당 및 올리고당 추출물....1000 ㎎Kelp polysaccharide and oligosaccharide extract of Example 1. 1000 mg
비타민 혼합물...................................적량Vitamin Blend ...
비타민 A 아세테이트.............................70 ㎍Vitamin A Acetate ............... 70 μg
비타민 E.......................................1.0 ㎎Vitamin E .................................. 1.0 mg
비타민 B1......................................0.13 ㎎Vitamin B1 ..................... 0.13 mg
비타민 B2......................................0.15 ㎎Vitamin B2 ..................... 0.15 mg
비타민 B6......................................0.5 ㎎Vitamin B6 ......................................... 0.5 mg
비타민 B12.....................................0.2 ㎍Vitamin B12 ................................. 0.2 μg
비타민 C.......................................10 ㎎Vitamin C ......................................... 10 mg
비오틴.........................................10 ㎍Biotin ......................................... 10 μg
니코틴산아미드.................................1.7 ㎎Nicotinic Acid Amide ... 1.7 mg
엽산...........................................50 ㎍Folic acid ......................................... 50 ㎍
판토텐산 칼슘..................................0.5 ㎎Calcium Pantothenate ..................... 0.5 mg
무기질 혼합물...................................적량Inorganic Mixture ...
황산제1철......................................1.75 ㎎Ferrous Sulfate ............... 1.75 mg
산화아연.......................................0.82 ㎎Zinc Oxide ............... 0.82 mg
탄산마그네슘...................................25.3 ㎎Magnesium Carbonate ......................................... 25.3 mg
제1인산칼륨....................................15 ㎎Potassium monophosphate ......................................... 15 mg
제2인산칼슘....................................55 ㎎Dicalcium Phosphate Diluent ... 55 mg
구연산칼륨.....................................90 ㎎Potassium Citrate ............... 90 mg
탄산칼슘.......................................100 ㎎Calcium Carbonate ... 100 mg
염화마그네슘..................................24.8 ㎎Magnesium Chloride ......................................... 24.8 mg
상기의 비타민 및 미네랄 혼합물의 조성비는 비교적 건강식품에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 그 배합비를 임의로 변형 실시하여도 무방하며, 통상의 건강식품 제조방법에 따라 상기의 성분을 혼합한 다음, 과립을 제조하고, 통상의 방법에 따라 건강식품 조성물 제조에 사용할 수 있다.Although the composition ratio of the above-mentioned vitamin and mineral mixtures is mixed with a component suitable for a health food in a preferred embodiment, the compounding ratio may be arbitrarily modified, and the above ingredients are mixed according to a conventional health food manufacturing method. The granules may be prepared and used for preparing a health food composition according to a conventional method.
제제예 2. 건강 음료의 제조Formulation Example 2 Preparation of Healthy Drinks
실시예 1의 다시마 다당 및 올리고당 추출물......1000 ㎎Seaweed polysaccharide and oligosaccharide extract of Example 1 ...... 1000 mg
구연산.........................................1000 ㎎Citric Acid ......................................... 1000 mg
올리고당.......................................100 gOligosaccharide ......................................... 100 g
매실농축액......................................2 gPlum concentrate ........................... 2 g
타우린..........................................1 gTaurine ......................................... 1 g
정제수를 가하여...............................전체 900 ㎖Purified water is added ................... 900 ml
통상의 건강음료 제조방법에 따라 상기의 성분을 혼합한 다음, 약 1시간동안 85 ℃에서 교반 가열한 후, 만들어진 용액을 여과하여 멸균된 2 ℓ 용기에 취득하여 밀봉 멸균한 뒤 냉장 보관한 다음 본 발명의 건강음료 조성물 제조에 사용한다. After mixing the above components in accordance with the conventional healthy beverage manufacturing method, and stirred and heated at 85 ℃ for about 1 hour, the resulting solution is filtered and obtained in a sterilized 2 L container, sealed sterilization and refrigerated Used to prepare the healthy beverage composition of the invention.
상기 조성비는 비교적 기호음료에 적합한 성분을 바람직한 실시예로 혼합 조성하였지만, 수요계층, 수요국가, 사용용도 등 지역적, 민족적 기호도에 따라서 그 배합비를 임의로 변형 실시하여도 무방하다.Although the composition ratio is mixed with a relatively suitable component for a preferred beverage in a preferred embodiment, the compounding ratio may be arbitrarily modified according to regional and ethnic preferences such as demand hierarchy, demand country, and usage.
상술한 바와 같이, 본 발명의 산 및 고온가열 처리하여 얻어진 다시마 다당 및 올리고당 추출물은 소장내의 음식물의 이동 속도를 촉진시키고, 장관의 운동을 촉진하여 배변을 원활하게 하므로, 변비 개선 및 예방용 기능성 식품 조성물로써, 기능성 음료 등의 건강기능식품에 사용할 수 있다. As described above, the kelp polysaccharide and oligosaccharide extract obtained by the acid and high temperature heating treatment of the present invention promotes the movement speed of the food in the small intestine, promotes the movement of the intestine, and facilitates bowel movement, thereby improving constipation and preventing functional food. As a composition, it can be used for health functional foods, such as a functional drink.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030086671A KR20050053071A (en) | 2003-12-02 | 2003-12-02 | Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020030086671A KR20050053071A (en) | 2003-12-02 | 2003-12-02 | Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20050053071A true KR20050053071A (en) | 2005-06-08 |
Family
ID=37248827
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030086671A KR20050053071A (en) | 2003-12-02 | 2003-12-02 | Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20050053071A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100734944B1 (en) | 2007-01-15 | 2007-07-03 | 김재현 | Functional food-composition with calcium lactate and rice bran |
-
2003
- 2003-12-02 KR KR1020030086671A patent/KR20050053071A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100734944B1 (en) | 2007-01-15 | 2007-07-03 | 김재현 | Functional food-composition with calcium lactate and rice bran |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101433188B1 (en) | Composition For Relieving Alcohol-induced Hangover Comprising Starch, Amino Acids, Active Complex Vitamin And Oriental Herb Medicine materials AND, The Manufacturing Method Thereof | |
KR101615199B1 (en) | Functional compositions for relieving hangovers and protecting a liver, healthy food and food additive comprising the same | |
KR101183981B1 (en) | Food and beverage composition containing extract of black waxy rice with giant embryo | |
KR20100064120A (en) | Constipation releaving health food composition containing aloe vera and aloe aborescens | |
KR20070089309A (en) | The preparation method of concentrated material of gelidium sp. showing antibacterial, anti-oxidative and antitumor activities and the functional food composition comprising the same | |
KR20100128941A (en) | Functional composition for the prevention and improvement of hangover, and food and food additive having the same | |
KR101045279B1 (en) | Composition of functional food with weight loss effect | |
WO2007007994A1 (en) | Food composition for improving liver function comprising a lonicera caerulea l. var. edulis extract | |
KR100696589B1 (en) | Composition comprising the extract of Theragra chalcogramma, Hovenia dulcis and Viscum album var. coloratum and catechins of Pueraria thunbergiana for treating or alleviating hangover syndrom and protecting liver | |
KR102437419B1 (en) | Composition for removing hangover | |
KR100977076B1 (en) | Anti-helicobacter composition containing schizandra sp extract and rubus careabus extract | |
KR100968955B1 (en) | Jujube pill and and method for manufacturing thereof | |
KR100628534B1 (en) | The preparation method of concentrated material of Laminaria and the health care food comprising the same | |
KR20050053071A (en) | Functional food composition comprising the polysaccharide and oligosaccharide extract of laminaria for improvement and prevention of constipation | |
KR100690071B1 (en) | Functional composition for the prevention and improvement of hangover | |
CN111802542A (en) | Cranberry plant beverage containing prebiotics and preparation method thereof | |
KR100872310B1 (en) | Functional composition for the cotinene metabolism improvement which is caused by with smoking and hangover removal, foods and food additive containing the same | |
KR100789399B1 (en) | Health Beverage composition containing the extract of Laminaria sp. Gelidium sp. and Grateloupia sp. | |
CN111184809A (en) | Food, health-care product or medicine composition for clearing and moistening throat and preparation method thereof | |
Borokini et al. | Comparative study on physiochemical parameters of functional beverages formulated from sorghum bicolor stem sheath and Hibiscus Sabdariffa | |
KR20200138472A (en) | Composition for relieving hangover comprising allium hookeri extract and fish collagen | |
KR20150120741A (en) | Composition for preventing or improving atopic dermatitis comprising mixture of persimmon peel, persimmon flesh, persimmon leaf and Diospyros lotus leaf as effective component | |
KR102671658B1 (en) | Dietary fiber composition for promoting defecation and improving cholesterol containing psyllium hull and manufacturing method thereof | |
KR102457306B1 (en) | Health function food composition comprising lactobacillus for improving skin and vowel function and method of preparing the same | |
KR102523536B1 (en) | Fruits syrup comprising pericarp and manufacturing method of the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |